|
Volumn 513, Issue 7516, 2014, Pages 13-14
|
Ebola drug trials set to begin amid crisis.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EBOLA VACCINE;
COMPASSIONATE USE;
DRUG EFFECT;
EBOLA HEMORRHAGIC FEVER;
ELECTROLYTE BALANCE;
EPIDEMIC;
FLUID THERAPY;
HUMAN;
INTENSIVE CARE;
METHODOLOGY;
NORMAL HUMAN;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHYSIOLOGY;
STATISTICS;
WORLD HEALTH ORGANIZATION;
CLINICAL TRIALS, PHASE I AS TOPIC;
COMPASSIONATE USE TRIALS;
CRITICAL CARE;
DISEASE OUTBREAKS;
EBOLA VACCINES;
FLUID THERAPY;
HEALTHY VOLUNTEERS;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
WATER-ELECTROLYTE BALANCE;
WORLD HEALTH ORGANIZATION;
|
EID: 84907205282
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/513013a Document Type: Note |
Times cited : (18)
|
References (0)
|